BioSpace News Archive

Report explores issues impacting rheumatology practices, including value-based care, biosimilars and challenges in caring for aging population

Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today announced that Jerry McLaughlin, President and Chief Executive Officer, will present a company overview at the BMO 2020 Prescriptions for Success Healthcare Conference on Tuesday, June 23, 2020, at 4:30 p.m. ET. A live webcast of the presentation will be available on the In

ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef calves, today announced receipt of a $500,000 subordinated loan from the Maine Technology Institute (MTI), whose mission is to support Maine’s innovation economy. This loan supports the Company’s inves

Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that the Company will be added to the Russell 3000® and 2000® Indexes, effective after the U.S. market opens on June 29, 2020, as part of the Russell Indexes annual reconstitution. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $9 trillion

Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, today announced that management will present at the BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference to be held virtually on Tuesday, June 23, 2020. Aquestive will present at 8:30 am EDT and is available for one-on-one meet

GenMark Diagnostics, Inc., a leading provider of automated, multiplex molecular diagnostic testing systems, has been selected by Vidant Health as its primary provider of rapid diagnostic testing.

Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it has appointed David Mott as an independent director to its Board of Directors. Mr. Mott brings more than three decades of global management, board and investment experience across numerous private and public biopharmaceutical companies. Prior to February 2020, he was the global head of

The American Gastroenterological Association announced it will be developing educational materials and safety protocols for gastroenterologists as they work to re-open their clinical practices during the COVID-19 pandemic.

InMode Ltd., a leading global provider of innovative medical technologies, is proud to announce Health Canada certification of Evolve Tone.

Bimini Health Tech announced today it has acquired Healeon Medical, Inc. Healeon represents an excellent addition to Bimini’s family of autologous products, continuing its mission of discoverin